PMID: 9533405Apr 9, 1998Paper

Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine

Neuroscience Letters
J E PrestonJ N Abbott

Abstract

The effect of a truncated form of the neurotoxin beta-amyloid peptide (A beta25-35) on rat brain vascular endothelial cells (RBE4 cells) was studied in cell culture. Toxic effects of the peptide were seen at 200 microg/ml A beta using a mitochondrial dehydrogenase activity (MTT) reduction assay, lactate dehydrogenase release and glucose consumption. Cell damage could be prevented completely at 200 microg/ml A beta and partially at 300 microg/ml A beta, by the dipeptide carnosine. Carnosine is a naturally occurring dipeptide found at high levels in brain tissue and innervated muscle of mammals including humans. Agents which share properties similar to carnosine, such as beta-alanine, homocarnosine, the anti-glycating agent aminoguanidine, and the antioxidant superoxide dismutase (SOD), also partially rescued cells, although not as effectively as carnosine. We postulate that the mechanism of carnosine protection lies in its anti-glycating and antioxidant activities, both of which are implicated in neuronal and endothelial cell damage during Alzheimer's disease. Carnosine may therefore be a useful therapeutic agent.

References

Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·D SchubertH Kimura
Apr 15, 1994·Journal of Neuroscience Research·J R CiallellaJ P McGillis
Aug 1, 1960·Archives of Biochemistry and Biophysics·C L DAVEY

❮ Previous
Next ❯

Citations

May 7, 2002·Journal of Neuroscience Research·Rinat TabakmanRon Kohen
Dec 7, 2011·Amino Acids·Francesco BelliaEnrico Rizzarelli
Mar 13, 2013·Amino Acids·Craig SaleRoger C Harris
Nov 21, 2007·Cellular and Molecular Neurobiology·Qiuli FuZhong Chen
Oct 13, 2006·Brain Research·Jianming XiangRichard F Keep
Jun 16, 2005·Mechanisms of Ageing and Development·Alan R Hipkiss
Jul 27, 2001·Mechanisms of Ageing and Development·A R HipkissM J Carrier
Nov 28, 2002·Advanced Drug Delivery Reviews·Amy H Moore, M K O'Banion
Sep 29, 1999·Progress in Neurobiology·L BonfantiA Fasolo
Sep 23, 1998·The International Journal of Biochemistry & Cell Biology·A R Hipkiss
Jun 1, 2007·BMC Neuroscience·Yousuke TsuneyoshiMitsuhiro Furuse
Feb 26, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesco BelliaEnrico Rizzarelli
Jun 24, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ke-Jie YinChung Y Hsu
Jun 29, 2006·Annals of the New York Academy of Sciences·Alan R Hipkiss
Oct 2, 2015·Aging and Disease·José H CararoGustavo da C Ferreira
May 1, 2009·Expert Review of Neurotherapeutics·Alan R Hipkiss
Nov 29, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Erwin E W JansenNanda M Verhoeven
Aug 8, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J XuC Y Hsu
Jul 29, 2015·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Marcela BrissovaRebecca L Hull
Mar 6, 2018·European Journal of Sport Science·Guilherme Giannini ArtioliRebecca Louise Jones
Dec 9, 2016·Physiology·Livius V d'UscioZvonimir S Katusic
Feb 27, 2013·Chembiochem : a European Journal of Chemical Biology·Francesco AttanasioEnrico Rizzarelli
Oct 27, 2007·Stroke; a Journal of Cerebral Circulation·Shawn N WhiteheadDavid F Cechetto
Jan 3, 2001·Microscopy Research and Technique·J E Preston
Jun 5, 2007·Journal of Neuroscience Research·Vincenzo Giuseppe NicolettiEnrico Rizzarelli
Sep 21, 2007·Nature Reviews. Neuroscience·Vittorio CalabreseAnna Maria Giuffrida Stella
Jun 27, 2008·Archiv der Pharmazie·Piera SozioAntonio Di Stefano
Oct 19, 2013·Physiological Reviews·Alexander A BoldyrevWim Derave

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.